News

The company's true organic growth is difficult to gauge given its high dependency on acquisitions.

Tilray Brands (TLRY) delivered earnings and revenue surprises of -2,050.00% and +9.14%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

Tilray will release its year-end numbers next week, which could have a significant impact on the stock.

Mr Watt said 43,000 so-called equity punk investors had joined forces for the bid.

The founder of BrewDog has launched an attempt to buy back the craft beer company months after it was rescued from administration by a US cannabis producer.

Watt posted news of his offer for BrewDog, now owned by US-listed Tilray Brands, on LinkedIn.

Aurora Cannabis' shares plunge 28% in three months as a cautious fiscal 2027 outlook overshadows record medical cannabis growth and global expansion.

The cannabis stock recently hit a new 52-week low.

Tilray's future extends beyond one regulatory hearing.

Quantum computing stocks are posting four-digit revenue growth rates, and the hype feels impossible to argue with until you remember that 3D Systems, Tilray, and Cisco all looked just as unstoppable right before they collapsed.

Cronos Group posts 40% Q1 revenue growth, gains share in Canada and expands abroad, but fierce cannabis competition keeps investors cautious.

Tilray Brands tried one thing, and it didn't work; now it is trying another approach.

Download the Complete Report Here Aurora Cannabis Inc. (ACB) Y26 Beat Underscores Medical Cannabis Momentum; FY27 Reset Reflects Canadian Reimbursement Cut, but Long-Term Growth Remains on Track. Key Takeaways: FY26 topped management’s outlook, with net revenue up 11% to C$320.6 million and medical cannabis revenue up 18%. 4Q revenue grew 10% y/y to C$84.8 million, […] The post Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Quarterly Update Report appeared first on

Trulieve's price has soared this year, while Tilray's has plummeted, but which is the better stock right now?

Cannabis stocks continue to benefit from Schedule III optimism, with investors now watching a June 29 hearing on broader marijuana rescheduling.

Tilray Brands Inc. (NASDAQ:TLRY) is one of the best sin stocks to buy now. On May 5, Tilray Brands Inc. (NASDAQ:TLRY) subsidiary BrewDog inked a 12-month partnership with Underbelly. The agreement is for the supply of beer at several UK festivals and venues. BrewDog is to become the official beer supplier at Christmas in Trafalgar […]

Tilray stock reaction to U.S. policy news and new Carlsberg partnership Tilray Brands (TLRY) is back in focus after U.S. cannabis reclassification headlines, a fresh multi-year partnership with Carlsberg, and a recent share price decline even as many cannabis peers gained. See our latest analysis for Tilray Brands. Despite the policy headlines and new Carlsberg partnership, Tilray’s share price has fallen 32.78% over the past month and 45.58% year to date, while the 1 year total shareholder...

International growth could make up for a lack of U.S. legalization progress